Skip to main content
227 results:
83. Proenkephalin (penKid®) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients  
SphingoTec GmbH (“SphingoTec”) announced today that the Acute Disease Quality Initiative (ADQI) recommends the use of novel biomarkers for AKI, including functional biomarkers as penKid®.  
84. Uniklinik RWTH Aachen is the first hospital to implement SphingoTec's innovative biomarkers in clinical routine with the aim of making intensive care diagnostics more precise  
The Uniklinik RWTH Aachen (“Uniklinik RWTH Aachen”) has successfully translated the collaboration for research and biomarker validation with SphingoTec GmbH (“SphingoTec”) into clinical routine.  
Search results 81 until 90 of 227